There are a number of services available to the MTP sector to assist with growing successful businesses.
Support from an IP, legal and regulatory perspective is readily available, while Australia is also at the forefront of clinical and research infrastructure. Moving along the continuum of product commercialisation, experts in market accessibility can be called upon, while communications professionals offer the perfect solutions for creating compelling investment propositions, brand building and spreading your good news.
Australia’s MTP sector is a vibrant one, and we have all the ancillary services required to take it to the next level. Here you’ll find some links to some valuable services to get you on your way.
Australian company Nanosonics developed the proprietary trophon® EPR for fast, automated high level disinfection (HLD) of ultrasound probes.
Amgen Australia conducts on average two ‘first in human’ studies every year, with almost half of their clinical trial research being early phase.
The Monash Institute of Pharmaceutical Sciences (MIPS) translates basic research into clinical trials to deliver new drug treatments, partnering with a number of international pharmaceutical companies for global reach.
Ms Sue MacLeman, Managing Director and CEO MTPConnect will present on Australia's medtech capabilities and competitive advantages at a medtech Showcase in Seoul.
MTPConnect is delighted to announce the appointment of three General Managers.
Wednesday, 10 August 2016, Canberra, Australia--MTPConnect and ARCS Australia have signed a Memorandum of Understanding (MoU), agreeing to work closely together for the benefit of the MedTech, biotechnology and pharmaceutical industry.